InsidersTradesSigma
Track the Scholar Rock Holding Corp. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €7.2bn. The latest transaction was disclosed on 6 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Mohammed Qatanani. All data is openly available.
Analysts rate Scholar Rock Holding Corp. Strong Buy (bullish), based on 16 analysts. Average price target: US$60.75.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
Scholar Rock Holding Corp. 是一家生物制药公司，专注于开发针对严重疾病的靶向疗法。该公司利用其药物发现平台来识别创新的治疗候选药物。